TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Pharma Nord Norge AS
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
35,260
|
39,160
|
34,358 |
Financial expenses |
26
|
32
|
34 |
Earnings before taxes |
1,028
|
1,181
|
1,076 |
Total assets |
18,263
|
20,497
|
17,487 |
Current assets |
16,471
|
18,596
|
15,479 |
Current liabilities |
17,013
|
19,038
|
15,641 |
Equity capital |
1,117
|
1,318
|
1,697 |
- share capital |
1,000
![]() |
1,000
![]() |
1,000 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
6.1%
|
6.4%
|
9.7% |
Turnover per employee | |||
Profit as a percentage of turnover |
2.9%
|
3.0%
|
3.1% |
Return on assets (ROA) |
5.8%
|
5.9%
|
6.3% |
Current ratio |
96.8%
|
97.7%
|
99.0% |
Return on equity (ROE) |
92.0%
|
89.6%
|
63.4% |
Change turnover |
-3,900
|
4,802
|
8,712 |
Change turnover % |
-10%
|
14%
|
34% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.